Page 148 - 南京医科大学自然版

第44卷第5期
·736 · 南 京 医 科 大 学 学 报 2024年5月

［17］LABADZHYAN A，MELMED S. Molecular targets in ac⁃ 2005
romegaly［J］. Front Endocrinol（Lausanne），2022，13： ［29］ZHOU Y Z，LI C Z，GAO H，et al. The effects of Smad3

1068061 on adrenocorticotropic hormone⁃secreting pituitary adeno⁃
·
［18］BOLANOWSKI M，KAłUZNY M，WITEK P，et al. Pasire⁃ ma development，cell proliferation，apoptosis，and hor⁃
otide⁃a novel somatostatin receptor ligand after 20 years mone secretion［J］. World Neurosurg，2018，114：e329-
of use［J］. Rev Endocr Metab Disord，2022，23（3）：601- e337
620 ［30］MIYADO M，FUKAMI M，OGATA T. MAMLD1 and dif⁃
［19］CASTELLNOU S，VASILJEVIC A，LAPRAS V，et al. ferences/disorders of sex development：an update［J］. Sex
SST5 expression and USP8 mutation in functioning and si⁃ Dev，2022，16（2⁃3）：126-137
lent corticotroph pituitary tumors［J］. Endocr Connect， ［31］QI J，NI W. Attenuation of MAMLD1 expression suppress⁃
2020，9（3）：243-253 es the growth and migratory properties of gonadotroph pi⁃
［20］MORENO⁃MORENO P，IBÁÑEZ⁃COSTA A，VENEGAS⁃ tuitary adenomas［J］. Pathol Oncol Res，2020，26（2）：
MORENO E，et al. Integrative clinical，radiological，and 937-946
molecular analysis for predicting remission and recur⁃ ［32］WANG A，NEILL S G，NEWMAN S，et al. The genomic
rence of cushing disease［J］. J Clin Endocrinol Metab， profiling and MAMLD1 expression in human and canines
2022，107（7）：e2938-e2951 with Cushing’s disease［J］. BMC Endocr Disord，2021，21
［21］GODBOUT A，MANAVELA M，DANILOWICZ K，et al. （1）：185
Cabergoline monotherapy in the long ⁃ term treatment of ［33］ZHANG S，CUI Y，M A X，et al. Single ⁃ cell transcrip⁃
Cushing’s disease［J］. Eur J Endocrinol，2010，163（5）： tomics identifies divergent developmental lineage trajecto⁃
709-716 ries during human pituitary development［J］. Nat Com⁃
［22］FUKUOKA H，SHICHI H，YAMAMOTO M，et al. The mun，2020，11（1）：5275
mechanisms underlying autonomous adrenocorticotropic ［34］ANDO M，GOTO M，HOJO M，et al. The proneural bHLH
hormone secretion in Cushing’s disease［J］. Int J Mol Sci， genes Mash1，Math3 and NeuroD are required for pitu⁃
2020，21（23）：9132 itary development［J］. J Mol Endocrinol，2018，61（3）：
［23］ANDONEGUI⁃ELGUERA S，SILVA⁃ROMáN G，PEñA⁃ 127-138
MARTÍNEZ E，et al. The genomic landscape of cortico⁃ ［35］ZHANG F，TANASA B，MERKURJEV D，et al. Enhancer
troph tumors：from silent adenomas to ACTH ⁃ Secreting ⁃bound LDB1 regulates a corticotrope promoter⁃pausing
carcinomas［J］. Int J Mol Sci，2022，23（9）：4861 repression program［J］. Proc Natl Acad Sci U S A，2015，
［24］SAKAMOTO H，FRIEL A M，WOOD A W，et al. Mecha⁃ 112（5）：1380-1385
nisms of Cables 1 gene inactivation in human ovarian can⁃ ［36］CHEN Z，JIA Q，ZHAO Z，et al. Transcription factor AS⁃
cer development［J］. Cancer Biol Ther，2008，7（2）：180- CL1 acts as a novel potential therapeutic target for the
188 treatment of the Cushing’s disease［J］. J Clin Endocrinol
［25］ROUSSEL⁃GERVAIS A，COUTURE C，LANGLAIS D，et Metab，2022，107（8）：2296-2306
al. The cables1 gene in glucocorticoid regulation of pitu⁃ ［37］CASAR⁃BOROTA O，BOLDT H B，ENGSTRÖM B E，et
itary corticotrope growth and cushing disease［J］. J Clin al. Corticotroph aggressive pituitary tumors and carcino⁃
Endocrinol Metab，2016，101（2）：513-522 mas frequently harbor ATRX mutations［J］. J Clin Endo⁃
［26］KORBONITS M，CHAHAL H S，KALTSAS G，et al. Ex⁃ crinol Metab，2021，106（4）：1183-1194
pression of phosphorylated p27（Kip1）protein and Jun ac⁃ ［38］DOGANŞEN S Ç，BILGIÇ B，YALIN G Y，et al. Clinical
tivation domain⁃binding protein 1 in human pituitary tu⁃ significance of granulation pattern in corticotroph pitu⁃
mors［J］. J Clin Endocrinol Metab，2002，87（6）：2635- itary adenomas. clinical significance of granulation pat⁃
2643 tern in corticotroph pituitary adenomas［J］. Turk Patoloji
［27］HERNÁNDEZ⁃RAMÍREZ LC，GAM R，VALDÉS N，et Derg，2019，35（1）：9-14
al. Loss⁃of⁃function mutations in the CABLES1 gene are a ［39］RAK B，MAKSYMOWICZ M，PęKUL M，et al. Clinical，
novel cause of Cushing’s disease［J］. Endocr Relat Can⁃ biological，radiological pathological and immediate post⁃
cer，2017，24（8）：379-392 operative remission of sparsely and densely granulated
［28］CHASSELOUP F，PANKRATZ N，LANE J，et al. Germ⁃ corticotroph pituitary tumors：a retrospective study of a co⁃
line CDKN1B loss ⁃ of ⁃ function variants cause pediatric hort of 277 patients with Cushing’s disease［J］. Front En⁃
Cushing ’s disease with or without an MEN4 pheno⁃ docrinol（Lausanne），2021，12：672178
type［J］. J Clin Endocrinol Metab，2020，105（6）：1983- ［40］BRZANA J，YEDINAK C G，GULTEKIN S H，et al.